Tony Butler
Stock Analyst at Rodman & Renshaw
(0.74)
# 3,982
Out of 5,058 analysts
96
Total ratings
31.91%
Success rate
-14.36%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tony Butler
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATRA Atara Biotherapeutics | Initiates: Buy | $25 | $13.22 | +89.11% | 2 | Dec 20, 2024 | |
| HURA TuHURA Biosciences | Initiates: Buy | $11 | $1.59 | +594.01% | 1 | Dec 19, 2024 | |
| BMEA Biomea Fusion | Upgrades: Buy | $18 | $1.00 | +1,700.00% | 4 | Sep 26, 2024 | |
| MURA Mural Oncology | Initiates: Buy | $15 | $2.10 | +615.99% | 1 | Jun 28, 2024 | |
| IPSC Century Therapeutics | Reiterates: Buy | $16 | $0.49 | +3,160.65% | 5 | Aug 10, 2023 | |
| FATE Fate Therapeutics | Reiterates: Buy | $10 | $1.00 | +900.00% | 4 | Aug 9, 2023 | |
| CRSP CRISPR Therapeutics AG | Reiterates: Buy | $75 | $49.29 | +52.16% | 8 | Aug 8, 2023 | |
| MRUS Merus | Reiterates: Buy | $35 | $95.98 | -63.53% | 7 | Aug 8, 2023 | |
| GTBP GT Biopharma | Reiterates: Hold | $60 | $0.71 | +8,410.64% | 5 | Aug 7, 2023 | |
| CGEN Compugen | Reiterates: Buy | $13 | $1.52 | +755.26% | 6 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $50 | $6.17 | +710.37% | 5 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.24 | +1,109.68% | 8 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $1.16 | +2,055.17% | 6 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $4.53 | +231.13% | 1 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $6.18 | +61.81% | 3 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $17 | $3.16 | +437.97% | 2 | Jul 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8.3 → $166 | $4.29 | +3,769.46% | 4 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $9.01 | +565.93% | 4 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $240 | $1.59 | +14,994.34% | 4 | Jun 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $6 | $0.33 | +1,698.56% | 1 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $360 | $1.92 | +18,620.75% | 1 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $5 → $2 | $4.51 | -55.65% | 6 | May 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $1.74 | +762.07% | 1 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $30 → $10 | $0.99 | +905.83% | 2 | Feb 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $4.85 | +209.28% | 1 | Nov 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $110 | $8.04 | +1,268.16% | 3 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $960 | $9.21 | +10,323.45% | 1 | Mar 2, 2020 |
Atara Biotherapeutics
Dec 20, 2024
Initiates: Buy
Price Target: $25
Current: $13.22
Upside: +89.11%
TuHURA Biosciences
Dec 19, 2024
Initiates: Buy
Price Target: $11
Current: $1.59
Upside: +594.01%
Biomea Fusion
Sep 26, 2024
Upgrades: Buy
Price Target: $18
Current: $1.00
Upside: +1,700.00%
Mural Oncology
Jun 28, 2024
Initiates: Buy
Price Target: $15
Current: $2.10
Upside: +615.99%
Century Therapeutics
Aug 10, 2023
Reiterates: Buy
Price Target: $16
Current: $0.49
Upside: +3,160.65%
Fate Therapeutics
Aug 9, 2023
Reiterates: Buy
Price Target: $10
Current: $1.00
Upside: +900.00%
CRISPR Therapeutics AG
Aug 8, 2023
Reiterates: Buy
Price Target: $75
Current: $49.29
Upside: +52.16%
Merus
Aug 8, 2023
Reiterates: Buy
Price Target: $35
Current: $95.98
Upside: -63.53%
GT Biopharma
Aug 7, 2023
Reiterates: Hold
Price Target: $60
Current: $0.71
Upside: +8,410.64%
Compugen
Aug 7, 2023
Reiterates: Buy
Price Target: $13
Current: $1.52
Upside: +755.26%
Aug 3, 2023
Reiterates: Buy
Price Target: $50
Current: $6.17
Upside: +710.37%
Aug 3, 2023
Reiterates: Buy
Price Target: $15
Current: $1.24
Upside: +1,109.68%
Aug 2, 2023
Reiterates: Buy
Price Target: $25
Current: $1.16
Upside: +2,055.17%
Jul 31, 2023
Initiates: Buy
Price Target: $15
Current: $4.53
Upside: +231.13%
Jul 12, 2023
Reiterates: Buy
Price Target: $10
Current: $6.18
Upside: +61.81%
Jul 7, 2023
Reiterates: Buy
Price Target: $17
Current: $3.16
Upside: +437.97%
Jul 3, 2023
Reiterates: Buy
Price Target: $8.3 → $166
Current: $4.29
Upside: +3,769.46%
Jun 7, 2023
Reiterates: Buy
Price Target: $60
Current: $9.01
Upside: +565.93%
Jun 5, 2023
Reiterates: Buy
Price Target: $240
Current: $1.59
Upside: +14,994.34%
Jun 1, 2023
Assumes: Buy
Price Target: $6
Current: $0.33
Upside: +1,698.56%
Jun 1, 2023
Assumes: Buy
Price Target: $360
Current: $1.92
Upside: +18,620.75%
May 30, 2023
Maintains: Hold
Price Target: $5 → $2
Current: $4.51
Upside: -55.65%
Jan 5, 2023
Initiates: Buy
Price Target: $15
Current: $1.74
Upside: +762.07%
Feb 17, 2022
Downgrades: Neutral
Price Target: $30 → $10
Current: $0.99
Upside: +905.83%
Nov 19, 2021
Initiates: Buy
Price Target: $15
Current: $4.85
Upside: +209.28%
Jun 28, 2021
Maintains: Buy
Price Target: $80 → $110
Current: $8.04
Upside: +1,268.16%
Mar 2, 2020
Initiates: Buy
Price Target: $960
Current: $9.21
Upside: +10,323.45%